Home ›
Gastric Cancer Trials ›
NCT06597227
Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy
We plan to evaluate the efficacy and safety of proximal gastric vs. total gastric radical resection after SOX combined with anti-PD-1 neoadjuvant therapy in locally advanced upper gastric cancer
Trial Details
NCT ID NCT06597227
Phase NA
Sponsor Guihua Wang
Status RECRUITING
Cancer Type Gastric Cancer
Interventions Proximal radical gastrectomy Total radical gastrectomy
Locations (sample) Wuhan, Hubei, China|30.58333,114.26667
Key Eligibility Criteria
To be eligible to participate in this study, all patients must meet all the following criteria: The subjects voluntarily joined the study and were able to sign the informed consent with good compliance; Age 18-75 years old (at the time of signing the informed consent), both male and female; Histologically and/or cytologically confirmed upper gastric carcinoma (adenocarcinoma), locally advanced according to AJCC Edition 8 criteria, cT3-…
For full eligibility, visit ClinicalTrials.gov .
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Gastric Cancer Trials on Trialify →